Clinical profile of idiopathic angioedema based on severity and treatment response is independent of the presence of concomitant wheals

Abstract Background Idiopathic angioedema varies in disease severity and treatment response, possibly due to different pathophysiological mechanisms. The presence of wheals is an indicator for histamine‐mediated angioedema. Idiopathic angioedema patients are treated in accordance with chronic sponta...

Full description

Saved in:
Bibliographic Details
Main Authors: Reineke Soegiharto (Author), Mehran Alizadeh Aghdam (Author), Andre C. Knulst (Author), Heike Röckmann (Author)
Format: Book
Published: Wiley, 2023-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_7431aebc866a4993979740cc21e9df43
042 |a dc 
100 1 0 |a Reineke Soegiharto  |e author 
700 1 0 |a Mehran Alizadeh Aghdam  |e author 
700 1 0 |a Andre C. Knulst  |e author 
700 1 0 |a Heike Röckmann  |e author 
245 0 0 |a Clinical profile of idiopathic angioedema based on severity and treatment response is independent of the presence of concomitant wheals 
260 |b Wiley,   |c 2023-03-01T00:00:00Z. 
500 |a 2768-6566 
500 |a 10.1002/jvc2.103 
520 |a Abstract Background Idiopathic angioedema varies in disease severity and treatment response, possibly due to different pathophysiological mechanisms. The presence of wheals is an indicator for histamine‐mediated angioedema. Idiopathic angioedema patients are treated in accordance with chronic spontaneous urticaria guidelines. Little is known about treatment effectiveness in idiopathic angioedema patients without wheals in comparison to idiopathic angioedema patients with concomitant wheals. Objective To describe the disease severity profile in patients with angioedema of unknown cause in relation to prophylactic treatment and the presence or absence of concomitant wheals. Methods In this retrospective cohort study, all records of angioedema patients visiting the outpatient clinic of the UMC Utrecht between January 2015 and March 2020 were screened. Patients with idiopathic angioedema, including those with concomitant wheals, were included. Attack frequency, patient‐reported disease control and attack treatment as indicator for severity were analysed in relation to prophylactic treatment at follow‐up and outcomes were compared between patients with and without concomitant subordinary wheals. Results Two hundred thirty‐six patients were included: 95% (139/236) with angioedema only and 41% (97/236) with angioedema and concomitant subordinary wheals. No prophylactic treatment was prescribed in 27% (64/236), with well‐controlled disease in 86% (25/29) of patients. Antihistamine monotherapy was used in 59% (139/236) of patients and resulted in well‐controlled disease in 68% (62/92). Add‐on treatment was prescribed in 14% (33/236) of patients, omalizumab in 9% (22/236) specifically, with complete response in 38% (6/16) of patients and low attack frequency in another 18% (3/16). Difficult‐to‐treat disease was seen in 8% (18/236), with no response to a fourfold dose of antihistamines or omalizumab. All findings were independent from the presence of concomitant wheals. Conclusion Angioedema is well manageable in the majority of patients without prophylactic therapy or antihistamine monotherapy, but a substantial proportion does not respond to antihistamines and/or omalizumab. Treatment response was independent of the presence or absence of concomitant wheals. 
546 |a EN 
690 |a angioedema 
690 |a bradykinine 
690 |a histaminergic 
690 |a wheals 
690 |a Dermatology 
690 |a RL1-803 
690 |a Diseases of the genitourinary system. Urology 
690 |a RC870-923 
655 7 |a article  |2 local 
786 0 |n JEADV Clinical Practice, Vol 2, Iss 1, Pp 114-121 (2023) 
787 0 |n https://doi.org/10.1002/jvc2.103 
787 0 |n https://doaj.org/toc/2768-6566 
856 4 1 |u https://doaj.org/article/7431aebc866a4993979740cc21e9df43  |z Connect to this object online.